Contact
searchSearch
HMP Global

Clinical & Industry News

Structural Heart Intervention
Investigational J-Valve System Shows Favorable One-Year Outcomes for Severe Aortic Regurgitation
06/25/2026
“This early feasibility study for J-Valve is encouraging," said Dean J. Kereiakes, MD, MSCAI. "It shows that a dedicated device designed for aortic regurgitation can achieve sustained valve performance, meaningful symptom improvement, and...
“This early feasibility study for J-Valve is encouraging," said Dean J. Kereiakes, MD, MSCAI. "It shows that a dedicated device designed for aortic regurgitation can achieve sustained valve performance, meaningful symptom improvement, and...
“This early feasibility study...
06/25/2026
Cath Lab Digest
Pacemaker in patient
Gene Therapy
Dutch Biotech Breakthrough Brings Biological Pacemaker Closer to Reality
06/25/2026
A pacemaker without a box under the skin. Without wires to the heart. And without a battery that needs to be replaced every 7-10 years. It sounds like something from the distant future, but Dutch researchers at biotech company PacingCure have...
A pacemaker without a box under the skin. Without wires to the heart. And without a battery that needs to be replaced every 7-10 years. It sounds like something from the distant future, but Dutch researchers at biotech company PacingCure have...
A pacemaker without a box under...
06/25/2026
Cath Lab Digest
Intravascular Lithotripsy
Johnson & Johnson Begins Enrollment in Pivotal Studies Evaluating First-of-its-Kind Carotid IVL Platform
06/25/2026
The U.S. IDE study program will evaluate the purpose-built Shockwave™ SkyRunner Carotid IVL System designed to address the challenges of calcification in carotid arteries prior to stenting.
The U.S. IDE study program will evaluate the purpose-built Shockwave™ SkyRunner Carotid IVL System designed to address the challenges of calcification in carotid arteries prior to stenting.
The U.S. IDE study program will...
06/25/2026
Cath Lab Digest
Atherosclerosis
SCCT Catalyst Award Supports CCTA Research on Menopause Hormone Therapy and Coronary Plaque
06/25/2026
ARLINGTON, VA — The Society of Cardiovascular Computed Tomography (SCCT) selected Ido Avivi, MD as the second recipient of the Chinnaiyan Catalyst Award for Women's Cardiovascular Health Research. The award — established in 2025 by SCCT...
ARLINGTON, VA — The Society of Cardiovascular Computed Tomography (SCCT) selected Ido Avivi, MD as the second recipient of the Chinnaiyan Catalyst Award for Women's Cardiovascular Health Research. The award — established in 2025 by SCCT...
ARLINGTON, VA — The Society of...
06/25/2026
Cath Lab Digest
Anchor Balloon is the medical-device startup behind the patented AngioLock Balloon—a “zip-line” catheter designed to stabilize and simplify precise stent delivery in complex coronary anatomy. 
Device Innovations
Junkosha Awards Recognize Balloon Catheter and Steerable Guidewire Innovations
06/24/2026
Junkosha, pioneers of sophisticated fluoropolymer application technologies, has concluded its highly successful third Technology Innovator of the Year Award through a live stream YouTube ceremony held on June 17th 2026. Up first was Dr....
Junkosha, pioneers of sophisticated fluoropolymer application technologies, has concluded its highly successful third Technology Innovator of the Year Award through a live stream YouTube ceremony held on June 17th 2026. Up first was Dr....
Junkosha, pioneers of...
06/24/2026
Cath Lab Digest
New Guiding Sheath
Volante™ Steerable Guiding Sheath Now Available in US
06/23/2026
Key Highlights  The Volante Steerable Guiding Sheath is designed to facilitate intracardiac, renal and peripheral placement of diagnostic and therapeutic devices.  With five different lengths and six different French sizes,...
Key Highlights  The Volante Steerable Guiding Sheath is designed to facilitate intracardiac, renal and peripheral placement of diagnostic and therapeutic devices.  With five different lengths and six different French sizes,...
Key Highlights  The...
06/23/2026
Vascular Disease Management
Clinical Trials
SYMPHONY-PE Trial Post-Hoc Analysis Suggests Early Thrombectomy May Improve Key Measures of Heart Recovery in Intermediate-Risk Pulmonary Embolism
06/18/2026
Treating patients within 12 hours of diagnosis may be associated with greater improvement in acute hemodynamic and right ventricle measures compared to treatment after 12 hours, with similar safety outcomes between groups.
Treating patients within 12 hours of diagnosis may be associated with greater improvement in acute hemodynamic and right ventricle measures compared to treatment after 12 hours, with similar safety outcomes between groups.
Treating patients within 12...
06/18/2026
Cath Lab Digest
Team Communication
IB Nimble 2 Adds In-App DICOM Viewing for Real-Time Multidisciplinary Collaboration
06/17/2026
The most notable enhancement is the ability to view medical images directly within the app. This long-awaited feature enables care teams to review imaging in real time.
The most notable enhancement is the ability to view medical images directly within the app. This long-awaited feature enables care teams to review imaging in real time.
The most notable enhancement is...
06/17/2026
Cath Lab Digest
Clinical Trials
VahatiCor Enrolls First U.S. Patient in SERRA-I Clinical Study of A-FLUX Reducer System® for Coronary Microvascular Dysfunction (CMD)
06/17/2026
A-FLUX Reducer System® enters U.S. clinical evaluation in the SERRA-I early feasibility study.
A-FLUX Reducer System® enters U.S. clinical evaluation in the SERRA-I early feasibility study.
A-FLUX Reducer System® enters...
06/17/2026
Cath Lab Digest
Aortic Stenosis
AccurKardia's AK-AVS™ Aortic Valve Stenosis Screening Software Accepted into FDA Total Product Life Cycle Advisory Program
06/16/2026
AK-AVS, which received FDA Breakthrough Device Designation in October 2024, is an ECG-based AI algorithm intended to aid in the diagnosis of moderate to severe aortic valve stenosis in adult patients 22 years and older, utilizing data derived...
AK-AVS, which received FDA Breakthrough Device Designation in October 2024, is an ECG-based AI algorithm intended to aid in the diagnosis of moderate to severe aortic valve stenosis in adult patients 22 years and older, utilizing data derived...
AK-AVS, which received FDA...
06/16/2026
Cath Lab Digest

Subscriber

Cath Lab Digest Newsletter

Clinical & Industry News

Structural Heart Intervention
Investigational J-Valve System Shows Favorable One-Year Outcomes for Severe Aortic Regurgitation
06/25/2026
“This early feasibility study for J-Valve is encouraging," said Dean J. Kereiakes, MD, MSCAI. "It shows that a dedicated device designed for aortic regurgitation can achieve sustained valve performance, meaningful symptom improvement, and...
“This early feasibility study for J-Valve is encouraging," said Dean J. Kereiakes, MD, MSCAI. "It shows that a dedicated device designed for aortic regurgitation can achieve sustained valve performance, meaningful symptom improvement, and...
“This early feasibility study...
06/25/2026
Cath Lab Digest
Pacemaker in patient
Gene Therapy
Dutch Biotech Breakthrough Brings Biological Pacemaker Closer to Reality
06/25/2026
A pacemaker without a box under the skin. Without wires to the heart. And without a battery that needs to be replaced every 7-10 years. It sounds like something from the distant future, but Dutch researchers at biotech company PacingCure have...
A pacemaker without a box under the skin. Without wires to the heart. And without a battery that needs to be replaced every 7-10 years. It sounds like something from the distant future, but Dutch researchers at biotech company PacingCure have...
A pacemaker without a box under...
06/25/2026
Cath Lab Digest
Intravascular Lithotripsy
Johnson & Johnson Begins Enrollment in Pivotal Studies Evaluating First-of-its-Kind Carotid IVL Platform
06/25/2026
The U.S. IDE study program will evaluate the purpose-built Shockwave™ SkyRunner Carotid IVL System designed to address the challenges of calcification in carotid arteries prior to stenting.
The U.S. IDE study program will evaluate the purpose-built Shockwave™ SkyRunner Carotid IVL System designed to address the challenges of calcification in carotid arteries prior to stenting.
The U.S. IDE study program will...
06/25/2026
Cath Lab Digest
Atherosclerosis
SCCT Catalyst Award Supports CCTA Research on Menopause Hormone Therapy and Coronary Plaque
06/25/2026
ARLINGTON, VA — The Society of Cardiovascular Computed Tomography (SCCT) selected Ido Avivi, MD as the second recipient of the Chinnaiyan Catalyst Award for Women's Cardiovascular Health Research. The award — established in 2025 by SCCT...
ARLINGTON, VA — The Society of Cardiovascular Computed Tomography (SCCT) selected Ido Avivi, MD as the second recipient of the Chinnaiyan Catalyst Award for Women's Cardiovascular Health Research. The award — established in 2025 by SCCT...
ARLINGTON, VA — The Society of...
06/25/2026
Cath Lab Digest
Anchor Balloon is the medical-device startup behind the patented AngioLock Balloon—a “zip-line” catheter designed to stabilize and simplify precise stent delivery in complex coronary anatomy. 
Device Innovations
Junkosha Awards Recognize Balloon Catheter and Steerable Guidewire Innovations
06/24/2026
Junkosha, pioneers of sophisticated fluoropolymer application technologies, has concluded its highly successful third Technology Innovator of the Year Award through a live stream YouTube ceremony held on June 17th 2026. Up first was Dr....
Junkosha, pioneers of sophisticated fluoropolymer application technologies, has concluded its highly successful third Technology Innovator of the Year Award through a live stream YouTube ceremony held on June 17th 2026. Up first was Dr....
Junkosha, pioneers of...
06/24/2026
Cath Lab Digest
New Guiding Sheath
Volante™ Steerable Guiding Sheath Now Available in US
06/23/2026
Key Highlights  The Volante Steerable Guiding Sheath is designed to facilitate intracardiac, renal and peripheral placement of diagnostic and therapeutic devices.  With five different lengths and six different French sizes,...
Key Highlights  The Volante Steerable Guiding Sheath is designed to facilitate intracardiac, renal and peripheral placement of diagnostic and therapeutic devices.  With five different lengths and six different French sizes,...
Key Highlights  The...
06/23/2026
Vascular Disease Management
Clinical Trials
SYMPHONY-PE Trial Post-Hoc Analysis Suggests Early Thrombectomy May Improve Key Measures of Heart Recovery in Intermediate-Risk Pulmonary Embolism
06/18/2026
Treating patients within 12 hours of diagnosis may be associated with greater improvement in acute hemodynamic and right ventricle measures compared to treatment after 12 hours, with similar safety outcomes between groups.
Treating patients within 12 hours of diagnosis may be associated with greater improvement in acute hemodynamic and right ventricle measures compared to treatment after 12 hours, with similar safety outcomes between groups.
Treating patients within 12...
06/18/2026
Cath Lab Digest
Team Communication
IB Nimble 2 Adds In-App DICOM Viewing for Real-Time Multidisciplinary Collaboration
06/17/2026
The most notable enhancement is the ability to view medical images directly within the app. This long-awaited feature enables care teams to review imaging in real time.
The most notable enhancement is the ability to view medical images directly within the app. This long-awaited feature enables care teams to review imaging in real time.
The most notable enhancement is...
06/17/2026
Cath Lab Digest
Clinical Trials
VahatiCor Enrolls First U.S. Patient in SERRA-I Clinical Study of A-FLUX Reducer System® for Coronary Microvascular Dysfunction (CMD)
06/17/2026
A-FLUX Reducer System® enters U.S. clinical evaluation in the SERRA-I early feasibility study.
A-FLUX Reducer System® enters U.S. clinical evaluation in the SERRA-I early feasibility study.
A-FLUX Reducer System® enters...
06/17/2026
Cath Lab Digest
Aortic Stenosis
AccurKardia's AK-AVS™ Aortic Valve Stenosis Screening Software Accepted into FDA Total Product Life Cycle Advisory Program
06/16/2026
AK-AVS, which received FDA Breakthrough Device Designation in October 2024, is an ECG-based AI algorithm intended to aid in the diagnosis of moderate to severe aortic valve stenosis in adult patients 22 years and older, utilizing data derived...
AK-AVS, which received FDA Breakthrough Device Designation in October 2024, is an ECG-based AI algorithm intended to aid in the diagnosis of moderate to severe aortic valve stenosis in adult patients 22 years and older, utilizing data derived...
AK-AVS, which received FDA...
06/16/2026
Cath Lab Digest

HMP Global Products

Events

HMP Education Logo
HMP Omnimedia Logo
HMP Europe Logo
© 2026 HMP Global. All Rights Reserved.
Cookie Policy Privacy Policy Terms of Use